Back Refine search Reset
Please choose a search criteria from below
Filters Clear all

Best Medical Oncologist in Birmingham, UK

0 results found for Medical Oncologist in Birmingham, UK

Sort by:
We didn't find any results for your search within 15 miles of Birmingham, UK
Here are closest specialists matching your search
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
39 years of experience
Breast Cancer, Chemotherapy, Biological Therapy, Deep Inspiration Breath Hold (DIBH) + 6 more

Dr Craig MacMillan undertook his initial medical training at the university of Leeds, graduating in 1981. He is a Clinical Oncologist specialising in the treatment of Breast Cancer and is highly trained in providing chemotherapy and radiotherapy treatments for Cancer patients, with a wealth of experience in his field.

During his time as a consultant, the range and variety of treatments for people with cancer have expanded considerably, and Dr Macmillan is committed to bringing these developments to patients; continuously furthering his education and undertaking extensive research which is a great passion of his. His research interests centre on participation in multi-centre national and international clinical trials; with a view to the evolution and bettering of patient care.

Diseases, Medical Tests and Treatments

  • Non-surgical treatment of cancer
  • Chemotherapy
  • Radiotherapy
  • Biological treatments
  • Breast Cancer
Read more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
Bladder Cancer, Bowel Cancer, Colon Cancer, Colorectal Cancer + 5 more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
22 years of experience
Anal Cancer, Bowel Cancer, Breast Cancer, Breast Pain Management + 16 more

Dr Sarah Smith is the Clinical Director for Oncology and Palliative Care at Bedford Hospital and also holds the position as Governance Lead at Addenbrooke's Hospital, in addition to her private practice at GenesisCare Milton Keynes. She specialises in rectal, ovarian and endometrial cancer treatment in Bedford Hospital and has opened multiple nationally-recognised trials for local patient participation; striving to better patient treatment and care.

Dr Smith undertook her initial medical training at Imperial College London, graduating in 1998. Dr Smith also obtained BSc Medical Science at St. Bartholomew's and the Royal London School of Medicine in 1997.

After completing her general medical training, during which time she obtained her MRCP, she went onto the specialist registrar clinical oncology London training programme for five years, working at various London hospitals during this time, including University College Hospital, Mount Vernon Hospital and the Royal Marsden Hospital, and also obtained her FRCR. Dr Smith joined Bedford Hospital NHS Trust in 2008 as a Consultant Clinical Oncologist.

Diseases, Medical Tests and Treatments

  • Breast Pain Management
  • Chemotherapy
  • Clinical Trials
  • Radiotherapy
  • Stereotactic Ablative Radiotherapy (SABR)
  • Stereotactic Radiosurgery (SRS)
  • Video Consultation
  • Image Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Radiotherapy
  • RapidArc Or Volume Modulated Arc Therapy (VMAT)
  • Deep Inspiration Breath Hold
  • Flexible Cystoscopy
  • Palliative Radiotherapy
  • Surface Guided Radiotherapy (SGRT)
  • Anal Cancer
  • Bowel Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Gynaecological Cancers
  • Ovarian Cancer
  • Rectal Cancer
Read more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
Recommended by 1 specialist
30 years of experience
Biological Therapy, Bladder Cancer, Chemotherapy, Hormone Therapy + 4 more

Professor. Andrew Protheroe is an Associate Professor of Uro-Oncology within the University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre. He is a highly experienced Consultant Medical Oncologist specialising in managing urological cancer (prostate, kidney, bladder and testicular cancer) at Oxford since 2001. He qualified from St Thomas’s Hospital in London and after general medical training in London, trained in Oncology at St James’s University Hospital in Leeds. His PhD was in tumour immunology and the research was based at Leeds and the National Cancer Institute in Amsterdam as an Honorary ICRF Clinical Research fellow funded by a Northern and Yorkshire research award.  

Professor. Protheroe specialises in managing and overseeing patients with urological cancer providing specialised expert care to patients and their families covering all aspects of chemotherapy, hormonal therapy, immunotherapy, radium 223, growth inhibitors and novel therapies; giving plentiful options to give patients as many options as possible.

In addition to his other work, he is also one of the founding trustees for the urological cancer charity UCARE which supports research and awareness. He was also instrumental in setting up the kidney cancer support group (FROG), and helped to develop the prostate and bladder cancer support groups and set up initiatives to support men with testicular cancer.

It is clear from Professor Protheroe's work in both clinical practice, research and charity work that he is fully invested in the clinical care of his patients but also supporting their emotional wellbeing, giving them the best overall experience in their cancer journey.

Diseases, Medical Tests and Treatments
  • Immunotherapy
  • Personalised medicine for urological cancers
  • Gastroesophageal
  • Head and neck oncology
  • Chemotherapy
  • Haemato-oncology
  • Breast ultrasound
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer
Read more
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE - 58.88 miles
Churchill Hospital - 58.88 miles
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE
25 years of experience
Breast Cancer, Radiotherapy, Radiotherapy, Chemotherapy + 12 more

Dr. Shiroma De Silva-Minor is a Consultant Clinical Oncologist at The Oxford University Hospitals NHS Trust, having been appointed in 2008. Her special interest lies in the management of breast cancers.

Dr. De Silva-Minor graduated from University of Wales College of Medicine, Cardiff in 1995 and became a Member of the Royal College of Physicians (UK) in 1999. She then went on to train in her chosen specialty in Clinical Oncology, she trained as a specialist registrar in London, working at nationally renowned cancer centres including UCL The Middlesex Hospital, The Royal Free and The Royal Marsden Hospital. In 2003, Shiroma became a Fellow of the Royal College of Radiologists (UK) in 2003.

During a fellowship in Head and Neck Radiation Oncology at the prestigious Princess Margaret Hospital, Toronto, Shiroma was awarded the Prize for Academic Excellence by the institution and The University of Toronto for her research into the use of PET CT for identifying head and neck tumours for radiotherapy treatment; showing her excellence in the field of research as well as in her practice.

Dr. De Silva-Minor has presented her research at international conferences including The Annual meeting of the Canadian Association of Radiation Oncologists (CARO) in British Columbia and the American Society for Therapeutic Radiology and Oncology (ASTRO) in Colorado and in Philadelphia and at the European Society of Therapeutic Radiation and Oncology (ESTRO).

As a Clinical Oncologist, Dr. De Silva-Minor oversees the whole non-surgical aspect of a patients journey from genetic testing, counselling; through to treatments including chemotherapy, external beam radiotherapy (including partial breast treatment), Intraoperative radiotherapy, PARP inhibitors, CDK4/6 inhibitors and clinical trials; creating the best possible outcomes for patients

Diseases, Medical Tests and Treatments

  • Radiotherapy
  • Chemotherapy
  • Clinical Trials
  • Intraoperative radiotherapy
  • External beam radiotherapy
  • PARP inhibitors
  • CDK4/6 inhibitor
  • Breast Oncology
Read more
Video consultation
Dr Paul Mulholland - Medical Oncologist
Rickmansworth Road, Northwood, London, United Kingdom, HA6 2JW - 86.50 miles
BMI Bishops Wood Hospital - 86.50 miles
Rickmansworth Road, Northwood, London, United Kingdom, HA6 2JW
Recommended by 1 specialist
28 years of experience
Brain Cancer, Brain Tumours, Immunotherapy, Brain Metastasis + 3 more

Dr Mulholland is a medical Oncologist who exclusively treats brain cancer at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH) and Mount Vernon Cancer Centre.He is also an honorary senior lecturer at UCL and a training programme director. 

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally. 

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.




Diseases, Medical Tests and Treatments

  • Cancer prevention and screening 
  • Chemotherapy 
  • Brain cancer 
  • Neuro-endocrine tumours 
  • Central nervous system cancer 
  • Novel agents 
Read more
Video consultation
Dr Daniel Krell - Medical Oncologist
Heathbourne Road, Watford,, Bushey,Hertfordshire, United Kingdom, WD23 1RD - 88.47 miles
Spire Bushey Hospital - 88.47 miles
Heathbourne Road, Watford,, Bushey,Hertfordshire, United Kingdom, WD23 1RD
Recommended by 2 specialists
17 years of experience
Bile Duct Cancer (Cholangiocarcinoma), Adenocarcinoma, Bilary Cancer, Biological Therapy + 19 more

Dr Daniel Krell is a Consultant Oncologist, specialising in gastro-oesophageal, colorectal, pancreatic, liver and bile duct cancers and neuroendocrine tumours. He is experienced in using chemotherapy, targeted therapy and immunotherapy. Dr Krell also manages patients with cancer of unknown primary and is the clinical lead for this. He works as a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free Trust. He is also the clinical lead for Neuroendocrine tumour oncology at The Royal Free Hospital.

He undertook oncology training at University College and the Royal Free Hospitals in London. In addition to his primary medical degree, he also gained a Bachelor’s degree in immunology and microbiology, in addition to a DPhil in Clinical Medicine at the University of Oxford’s Wellcome Trust Centre for Human Genetics and was funded by Cancer Research UK and HCA. His research involved the design of models to investigate the role that genetic mutations in genes controlling cellular metabolism play in the development of cancer. This may help identify new therapeutic targets in this area. Dr Krell continues to be involved in clinical research and trials aimed at identifying new cancer therapies, focused on gastrointestinal, hepatobiliary and neuroendocrine tumours. He has published a number of peer-reviewed papers and presented at national and international conferences.

Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Immunotherapy
  • Biological Therapy
  • Genetic Testing
  • Liver Cancer
  • Biliary Cancer
  • Bowel Cancer
  • Colorectal Cancer
  • Oesophageal Cancer
  • Pancreatic Cancer
Read more
Video consultation
Dr Khurum Hayat Khan - Medical Oncologist
St Johns Wood, London, United Kingdom, NW8 7JA - 98.61 miles
The Wellington Hospital - 98.61 miles
St Johns Wood, London, United Kingdom, NW8 7JA
15 years of experience
Chemotherapy, Colorectal Cancer, Bowel Cancer, Pancreatic Cancer + 24 more

Dr Khan is a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum Consultant at Royal Marsden for 21 months, he took substantive consultant position in Gastrointestinal Oncology at UCLH. He also attends North Middlesex University Hospital (NMUH), where he is the Clinical Lead of Carcinoma of Unknown Primary (CUP) and Clinical Research in Oncology. Dr Khan was awarded the Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. He gained an MD(Res) degree under the supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. He was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as a trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

Dr Khan's main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

He presented and lectured in international conferences and public forums respectively. He published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Medicine, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. He also served as an expert member of the National Research and Ethics Committee.

Dr Khan also played an active role in improving the educational experience of the junior doctors nationally. He writes questions for MRCP(UK) and Medical Oncology exams and remains part of the national medical oncology recruitment panel. Dr Khan's publications can be accessed via the link below:

Dr Khan's seceratary Alanna Sarwar can be approached at +44(0)207 317 2659 and she can be emailed directly at

Diseases, Medical Tests and Treatments
  • Gastrointestinal Cancer Research
  • Colorectal cancers 
  • Colon cancers
  • Rectal cancers
  • Anal cancers 
  • Upper GI Cancers
  • Gastric cancers
  • oesophageal cancers
  • Hepato-biliary malignancies
  • Cholangiocarcinoma
  • Gall bladder cancers
  • Pancreatic cancers
  • Carcinoma of Unknown Primary
  • Gastrointestinal Cancer Research
  • Colorectal cancer
  • Newly diagnosed cancers
  • Molecular Genetics
  • Liquid Biopsies
Read more
15-17 Lodge Road, London, United Kingdom, NW8 7JA - 98.62 miles
Platinum Medical Centre - 98.62 miles
15-17 Lodge Road, London, United Kingdom, NW8 7JA
23 years of experience
Lung Cancer, Immunotherapy, Chemotherapy, Primary Lung Tumours + 5 more

Dr Thomas Newsom-Davis a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, especially lung cancer and mesothelioma. In 2015, he was awarded the Macmillan Innovation Excellence Award.


Dr Newsom-Davis completed his training at University College and Middlesex School of Medicine, London, in 1998, including First Class honours for his BSc. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals and completed a PhD in tumour immunology. He was appointed to Chelsea & Westminster Hospital in 2010.

Current Roles

Dr Newsom-Davis leads the lung cancer service for Chelsea & Westminster Hospital, and is Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organistion which supports and educates thoracic oncology profressionals across the United Kingdom. Dr Newsom-Davis is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT), and Chair of the HCA Healthcare UK Thoracic Oncology Board.


Dr Newsom-Davis has an active clinical trial portfolio, and has presented his work at National and International meetings. He has been an invited lecturer for organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Diseases, Medical Tests and Treatments

  • Immunotherapy, Targeted Therapy, Chemotherapy
  • Lung Cancer
  • Mesothelioma
Read more
Video consultation
Dr Jonathan Shamash - Medical Oncologist
22 Devonshire Place, London, United Kingdom, W1G 6JA - 99.45 miles
The Duchess of Devonshire Wing - 99.45 miles
22 Devonshire Place, London, United Kingdom, W1G 6JA
33 years of experience
Bladder Cancer, Bone Marrow Transplant, Chemotherapy, Clinical Trials + 12 more

Dr Jonathan Shamash is a Consultant Oncologist and is the Lead in Acute Oncology at St Bartholomew’s Hospital and has a further NHS base at Queen’s Hospital, Romford. Dr Shamash also sees patients privately, including at Leaders in Oncology Care. He graduated from the University of Edinburgh in 1987 and then undertook post graduate training in London, gaining an MD in in-vitro modelling of lymphoma.

Dr Shamash sub-specialises in genito-urinary cancers and thoracic malignancies. He has a special interest in managing complex oncology problems and delivering intensive treatments, including high dose Interleukin-2 and high does chemotherapy in testicular cancer. . Dr Shamash also chairs the supra-regional germ cell tumour multidisciplinary meeting and is a member of the NCRI testis clinical studies group. He leads various clinical studies in the management of testicular and prostate cancer and has published widely.

Read more